Patel HR, Mirsadraee S, Emberton M (2003) The patient’s dilemma: prostate cancer treatment choices. J Urol 169(3):828–833Patel HR Mirsadraee S & Emberton M (2003) The patient's dilemma: prostate cancer treatment choices. Journal of Urology, 169: 828 - 833....
Background: The purpose of this study was to assess treatment choices among men with prostate cancer who presented at The University of Texas MD Anderson Cancer Center multidisciplinary (MultiD) clinic compared with nationwide trends. Methods: In total, 4451 men with prostate cancer who presented ...
( 2008 ) Treatment 'mismatch' in early prostate cancer: do treatment choices take patient quality of life into account? Cancer 112 : 61 – 68 The three most common treatments for prostate cancer are similarly effective but have distinct adverse-effect profiles. . 2008 Nature Publishing Group...
Las Vegas--Brachytherapy is a growing treatment choice for menwith low-risk prostate cancer, although it is still selected by less than22% of men with the disease, according to San Francisco researchers. Theuse of androgen ablation has also increased, the researchers found in ananalysis of data...
Learn how Myriad’s genetic testing can help you and your provider navigate crucial prostate cancer treatment decisions with personalized genetic insights.
New research provides a road map to help guide patients’ choices, “and that takes a lot of the terror out of the decision-making,” said a prostate cancer survivor
While we know about physicians' involvement in the diagnosis and treatment of prostate cancer, little is known about others who assist men in dealing with the diagnosis and treatment choices, once they are diagnosed with early prostate cancer, but not yet treated. This pilot study explores if ...
Conclusions Specialist visits relate strongly to prostate cancer treatment choices. In light of these findings, prior evidence that specialists prefer the modality they themselves deliver and the lack of conclusive comparative studies demonstrating superiority of one modality over another, it is essential ...
Advances in ferroptosis for castration-resistant prostate cancer treatment: novel drug targets and combination therapy strategies Huizhu Chen Feng Lyu Xianshu Gao Review ArticleOpen Access28 Dec 2024 Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic...
Studies show that treatment choices based on partial information often lead to regret. Patients struggle to pinpoint correct knowledge amidst a deluge of data overload. With ashort, self-administered quiz, KEY directs readers to targeted information that is stage-specific. Written by 30 leading ex...